Pulmatrix, Inc.

Name: Pulmatrix, Inc. standardized financial statements, quarterly
Creator: Listed

PULMNasdaqCIK 1574235HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$3.0k, Q4 FY2024

Operating income−$1.0m, Q2 FY2026

Net income−$1.0m, Q2 FY2026

Pulmatrix, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	1,753	2,202	5,885	1,552	366	3.0	not reported	not reported	not reported	not reported	not reported	not reported
Research and development	$k	3,963	3,516	3,512	2,834	814	6.0	19.0	14.0	8.0	(3.0)	3.0	2.0
Selling, general and administrative	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$k	(3,939)	(2,225)	747	(5,901)	(2,657)	(1,952)	(1,847)	(1,548)	(866)	(908)	(1,292)	(1,046)
Interest expense	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$k	0.0	not reported	0.0	0.0	0.0	not reported	0.0	0.0	0.0	0.0	not reported	not reported
Net income	$k	(3,774)	(2,083)	825	(5,811)	(2,587)	(1,986)	(1,808)	(1,549)	(877)	(928)	(1,172)	(1,036)
Diluted EPS	$ per share	(1.03)	not reported	0.23	(1.59)	(0.71)	not reported	(0.50)	(0.42)	(0.24)	not reported	(0.32)	(0.29)
Basic EPS	$ per share	(1.03)	not reported	0.23	(1.59)	(0.71)	not reported	(0.50)	(0.42)	(0.24)	not reported	(0.32)	(0.29)

Balance sheet

Cash and equivalents$2.2m, Q2 FY2026

Shareholders' equity$2.6m, Q2 FY2026

Pulmatrix, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	21.3	19.2	16.3	12.4	10.8	9.5	7.7	5.8	4.8	4.1	3.3	2.2
Current assets	$m	23.2	20.8	17.6	15.6	11.4	9.9	8.0	6.1	5.0	4.1	4.5	3.2
Total assets	$m	36.8	34.0	30.4	15.8	11.5	9.9	8.1	6.2	5.0	4.1	4.5	3.2
Current liabilities	$m	4.4	3.9	3.1	2.5	0.6	0.9	0.9	0.5	0.2	0.3	0.9	0.7
Total liabilities	$m	16.9	16.0	11.4	2.5	0.6	1.0	0.9	0.5	0.2	0.3	0.9	0.7
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	19.9	18.0	19.0	13.3	10.9	8.9	7.1	5.6	4.7	3.8	3.6	2.6

Cash flow

Operating cash flow−$1.1m, Q2 FY2026

Capital expenditure$0, Q4 FY2024

Pulmatrix, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(4,142)	(2,011)	(2,719)	(3,677)	(3,059)	(1,261)	(1,813)	(1,883)	(1,031)	(706)	(1,067)	(1,106)
Capital expenditure	$k	313	305	154	244	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)3.65m, Q2 FY2026

Pulmatrix, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	3,478	3.7	3.7	3.7	3.7	3.7	3.7	3.7	3.7	3.7	3.7	3.7

Shares outstanding: 3.65m at Aug 13, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.